Overview

Special Drug Use Investigation for LAMICTAL® (Long Term)

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The objectives of this post-marketing surveillance (PMS) are to grasp the actual use of lamotrigine tablets to collect safety information in the long-term use according to seizure type and concomitant antiepileptic drug (AED), and to confirm its efficacy.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Anticonvulsants
Lamotrigine